WallStreetZenWallStreetZen

NASDAQ: ERNA
Ernexa Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ERNA stock forecasts and price targets.

ERNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-07

1 of 1

Forecast return on equity

Is ERNA forecast to generate an efficient return?

Company
-22.03%
Industry
33.33%
Market
146.98%
ERNA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ERNA forecast to generate an efficient return on assets?

Company
-14.33%
Industry
-0.47%
ERNA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ERNA earnings per share forecast

What is ERNA's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$18.38
Avg 2 year Forecast
-$1.90
Avg 3 year Forecast
-$1.30

ERNA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ERNA$5.89N/AN/A
XBIO$3.01N/AN/A
APM$0.87N/AN/A
CNSP$4.53N/AN/A
ACXP$1.54N/AN/A
View Top Biotech Stocks

Ernexa Therapeutics Stock Forecast FAQ

What is ERNA's earnings growth forecast for 2026-2028?

(NASDAQ: ERNA) Ernexa Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 24.03%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 68.81%.

Ernexa Therapeutics's earnings in 2026 is -$11,403,000.On average, 3 Wall Street analysts forecast ERNA's earnings for 2026 to be -$21,437,667, with the lowest ERNA earnings forecast at -$20,596,974, and the highest ERNA earnings forecast at -$22,068,187. On average, 3 Wall Street analysts forecast ERNA's earnings for 2027 to be -$2,212,767, with the lowest ERNA earnings forecast at -$2,125,992, and the highest ERNA earnings forecast at -$2,277,848.

In 2028, ERNA is forecast to generate -$1,510,868 in earnings, with the lowest earnings forecast at -$1,451,618 and the highest earnings forecast at -$1,555,305.

If you're new to stock investing, here's how to buy Ernexa Therapeutics stock.

What is ERNA's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: ERNA) forecast ROE is -22.03%, which is considered weak.

What is ERNA's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ERNA) Ernexa Therapeutics's current Earnings Per Share (EPS) is -$25.90. On average, analysts forecast that ERNA's EPS will be -$18.38 for 2026, with the lowest EPS forecast at -$17.66, and the highest EPS forecast at -$18.92. On average, analysts forecast that ERNA's EPS will be -$1.90 for 2027, with the lowest EPS forecast at -$1.82, and the highest EPS forecast at -$1.95. In 2028, ERNA's EPS is forecast to hit -$1.30 (min: -$1.24, max: -$1.33).

What is ERNA's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: ERNA) forecast ROA is -14.33%, which is lower than the forecast US Biotechnology industry average of -0.47%.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.